Sickle cell disease is a debilitating hematologic process that affects the entire body. Disease
manifestations in the abdomen most commonly result from vaso-occlusion, hemolysis, or …

Introduction This study describes the experience of a reference center using continuous
aspiration mechanical thrombectomy for acute high-and intermediate-high-risk pulmonary …

Purpose: Pulmonary embolism (PE) can lead to significant morbidity and mortality.
Thrombolytics are currently approved for the treatment of massive PE; however, the CHEST …

Pulmonary embolism onset is frequently neglected due to the non-specific character of its
symptoms. Pocket-size imaging devices (PSID) present an opportunity to implement imaging …

Background Left ventricular assist devices (LVAD) have been increasingly used in the
treatment of end-stage heart failure. While warfarin has been uniformly recommended in the …

Background: Ischemic stroke is the second, and pulmonary embolism (PE) is the third most
common cardiovascular cause of death after myocardial infarction. Data regarding risk …

The decision by pulmonary embolism response teams (PERTs) to utilize anticoagulation
(AC) with or without systemic thrombolysis (ST) or catheter-directed therapies (CDT) for …

Background: The purpose of this research was to investigate and compare the utilization of
the revised Geneva score, original PESI, and simplified PESI in predicting the long-term …

Background Venous thromboembolism (VTE) constitute a major global burden of disease.
Current international guidelines recommend treatment with anticoagulant therapy after VTE …

Aims Right atrial (RA) dilation and stretch provide prognostic information in patients with
cardiovascular diseases. We investigated the prevalence, confounding factors and …